市場調查報告書
商品編碼
1576633
免疫組織化學(IHC) 市場規模,佔有率,預測和趨勢分析:按提供,試劑盒,設備,方法流程,應用, 結束用戶 - 到2031年全球預測Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies]), Kits, Equipment [Staining, Imaging] Method Process, Application, End User - Global Forecast to 2031 |
預計到 2031 年,全球免疫組織化學市場將達到 40.8 億美元,2024 年至 2031 年複合年增長率為 7.2%。
該報告在廣泛的二級和一級研究以及對市場情景的詳細分析後,對主要市場驅動因素、限制因素、課題和機會進行了分析。全球免疫組織化學市場的成長是由老年人慢性病患病率不斷上升、對罕見疾病的興趣日益濃厚、人們對早期疾病診斷重要性的認識不斷提高、研發費用增加以及藥物發現和開發推動的。成長、傳染病負擔增加、研究活動資金增加以及醫療保健支出增加推動了這一趨勢。然而,標準化協議的缺乏限制了這個市場的成長。
此外,個人化醫療的傾向、基因組學和蛋白質組學的創新以及組織化學自動化的進步預計將為市場成長創造機會。然而,替代技術的可用性是全球免疫組織化學市場的主要課題。
(註:提供前5名公司的SWOT分析)
Immunohistochemistry (IHC) Market Size, Share, Forecast, & Trends Analysis by Offering (Reagents [Fixation, Buffer, Blocking, Antibodies], Kits, Equipment [Staining, Imaging] Method (ABC, CSA, PAP) Process, Application, End User-Global Forecast to 2031
The global immunohistochemistry market is projected to reach $4.08 billion by 2031 at a CAGR of 7.2% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global immunohistochemistry market is driven by the increasing prevalence of chronic diseases, among geriatric populations, increasing emphasis on rare diseases, growing awareness toward the importance of early disease diagnosis, rising R&D expenditure, growing demand for drug discovery and development, increasing burden of infectious diseases, increasing funding for research activities and rising healthcare expenditure. However, the lack of standardized protocols is restraining the growth of this market.
Furthermore, inclination toward personalized medicine, innovations in genomics and proteomics, and increasing automation in histochemistry are expected to generate market growth opportunities. However, the availability of alternative technologies is a major challenge in the global immunohistochemistry market.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the immunohistochemistry market are F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Eagle Biosciences, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S), Cell Signaling Technology, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Bio SB Inc. (U.S.), Biocare Medical, LLC. (U.S.), Bio-Genex Laboratories (U.S.), and CANDOR Bioscience GmbH (Germany).
Among all the offerings studied in this report, in 2024, the consumables segment is expected to account for the largest share of 68.4% of the immunohistochemistry market. The large market share of this segment is attributed to the advancements in kits and reagents enabling laboratories to perform multiple tests simultaneously, the rising burden of chronic diseases, and growing research in genetic and rare diseases by biopharmaceutical companies, contract research organizations, and research laboratories.
Among all the methods studied in this report, in 2024, the avidin-biotin complex is expected to account for the largest share of 30.8% of the immunohistochemistry market. The large market share of this segment is attributed to the various advantages of avidin-biotin complexes, such as resistivity to enzymatic reactions, change in pH, temperature, denaturation, and organic reagents, increased detection efficiency, low primary antibody consumption, and less assay time as compared to other methods.
Among all the applications studied in this report, in 2024, the clinical applications segment is expected to account for the largest share of the immunohistochemistry market. The segment's large market share can be attributed to the rising burden of cancer, the rising awareness of the advantages of immunohistochemistry testing for treatment purposes among healthcare professionals, and the increasing number of diagnostic laboratories. For instance, according to the American Cancer Society, around 20 million new cancer cases were newly diagnosed, and 9.7 million individuals died from the cancer worldwide in 2022. The number of cases is expected to reach up to 35 million by 2050. This increases the demand for immunohistochemistry tests for disease detection.
Among all the end users studied in this report, in 2024, the hospitals and diagnostic laboratories segment is expected to account for the largest share of the immunohistochemistry market. This segment's largest share is attributed to the increasing incidences of cancer, high healthcare expenditures, and the increasing number of hospitals in both developed and developing countries. Furthermore, patients' inclination toward hospitals due to well-established infrastructure, availability of skilled professionals, medical facilities, and advanced treatments also support the large market share of hospitals and diagnostic laboratories.
An in-depth analysis of the geographical scenario of the global immunohistochemistry market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of 13.0% during the forecast period. Accelerated growth in emerging countries in Asia-Pacific has relatively increased the emphasis of various governments towards the healthcare sector in terms of increased investments to enhance the accessibility to healthcare facilities and build better healthcare infrastructure.
Immunohistochemistry Market Assessment-by Offering
Note: other accessories include glass slides, racks & vials, mounting media, and organic solvents.
Immunohistochemistry Market Assessment-by Method
Immunohistochemistry Market Assessment-by Process
Immunohistochemistry Market Assessment-by Application
Note 1: Other applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies.
Note 2: Other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses.
Immunohistochemistry Market Assessment-by End User
Note: Other end users include forensic laboratories and transfusion laboratories.
Immunohistochemistry Market Assessment-by Geography
(Note: SWOT analysis of the top 5 companies will be provided.)